Alcorn Jane, Elbarbry Fawzy A, Allouh Mohammed Z, McNamara Patrick J
College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, Canada.
Drug Metab Dispos. 2007 Dec;35(12):2225-31. doi: 10.1124/dmd.107.017590. Epub 2007 Sep 19.
We previously reported an ontogeny model of hepatic cytochrome P450 (P450) activity that predicts in vivo P450 elimination from in vitro intrinsic clearance. The purpose of this study was to conduct investigations into key assumptions of the P450 ontogeny model using the developing rat model system. We used two developmentally dissimilar enzymes, CYP2E1 and CYP1A2, and male rats (n = 4) at age groups representing critical developmental stages. Total body and liver weights and hepatic microsomal protein contents were measured. Following high-performance liquid chromatography analysis, apparent K(M) and V(max) estimates were calculated using nonlinear regression analysis for CYP2E1- and CYP1A2-mediated chlorzoxazone 6-hydroxylation and methoxyresorufin O-dealkylation, and V(max) estimates for p-nitrophenol and phenacetin hydroxylations, respectively. Hepatic scaling factors and V(max) values provided estimates for infant scaling factors (ISF). The data show microsomal protein contents increased with postnatal age and reached adult values after postnatal day (PD) 7. Apparent K(M) values were similar at all developmental stages except at < or =PD7. Developmental increases in probe substrate V(max) values did not correlate with the biphasic increase in immunoquantifiable P450. The activity of two different probe substrates for each P450 covaried as a function of age. A plot of observed ISF values as a function of age reflected the developmental pattern of rat hepatic P450. In summation, these observations diverge from several of the model's assumptions. Further investigations are required to explain these inconsistencies and to investigate whether the developing rat may provide a predictive paradigm for pediatric risk assessment for P450-mediated elimination processes.
我们之前报道了一种肝细胞色素P450(P450)活性的个体发育模型,该模型可根据体外内在清除率预测体内P450清除率。本研究的目的是使用发育中的大鼠模型系统对P450个体发育模型的关键假设进行研究。我们使用了两种发育情况不同的酶,即CYP2E1和CYP1A2,并选用了处于关键发育阶段的雄性大鼠(n = 4)。测量了大鼠的总体重、肝脏重量以及肝微粒体蛋白含量。在进行高效液相色谱分析后,分别使用非线性回归分析计算CYP2E1和CYP1A2介导的氯唑沙宗6 - 羟基化以及甲氧基试卤灵O - 脱烷基反应的表观K(M)和V(max)估计值,以及对硝基苯酚和非那西丁羟基化反应的V(max)估计值。肝缩放因子和V(max)值提供了婴儿缩放因子(ISF)的估计值。数据显示,微粒体蛋白含量随出生后年龄增加而增加,并在出生后第7天(PD7)后达到成年值。除了在≤PD7时,表观K(M)值在所有发育阶段都相似。探针底物V(max)值的发育性增加与免疫可定量P450的双相增加不相关。每种P450的两种不同探针底物的活性随年龄变化而协同变化。将观察到的ISF值绘制为年龄的函数,反映了大鼠肝脏P450的发育模式。总之,这些观察结果与该模型的几个假设不同。需要进一步研究来解释这些不一致之处,并研究发育中的大鼠是否可为P450介导的消除过程的儿科风险评估提供预测范例。